8-K//Current report
TFF Pharmaceuticals, Inc. 8-K
Accession 0001213900-24-068991
CIK 0001733413operating
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:05 PM ET
Size
292.1 KB
Accession
0001213900-24-068991
Documents
- 8-Kea0211390-8k_tffpharma.htmPrimary
CURRENT REPORT
- EX-99.1ea0211390ex99-1_tffpharma.htm
PRESS RELEASE DATED AUGUST 14, 2024 REGARDING THE REGISTRANT'S FINANCIAL RESULTS FOR ITS FISCAL QUARTER ENDED JUNE 30, 2024
- EX-101.SCHtffp-20240814.xsd
XBRL SCHEMA FILE
- EX-101.LABtffp-20240814_lab.xml
XBRL LABEL FILE
- EX-101.PREtffp-20240814_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-24-068991-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0211390-8k_tffpharma_htm.xml
IDEA: XBRL DOCUMENT
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001733413
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:05 PM ET
- Size
- 292.1 KB